Phenotyping pulmonary hypertension in systemic sclerosis: a moving target.
作者信息
Mercurio Valentina, Hassoun Paul M
机构信息
1 Johns Hopkins University, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Baltimore, MD, USA.
2 Federico II University, Department of Translational Medical Sciences, Naples, Italy.
出版信息
Pulm Circ. 2018 Apr-Jun;8(2):2045894018785247. doi: 10.1177/2045894018785247.
Abstract
摘要
相似文献
1
Phenotyping pulmonary hypertension in systemic sclerosis: a moving target.系统性硬化症中肺动脉高压的表型分析：一个不断变化的目标。
Pulm Circ. 2018 Apr-Jun;8(2):2045894018785247. doi: 10.1177/2045894018785247.
2
[An up date on pulmonary hypertension related to systemic sclerosis].[系统性硬化症相关肺动脉高压的最新进展]
Przegl Lek. 2005;62(8):813-7.
3
Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.系统性硬化症患者肺动脉高压的管理
Integr Blood Press Control. 2020 Mar 23;13:15-29. doi: 10.2147/IBPC.S232038. eCollection 2020.
4
Lung or Heart-Lung Transplant in Pulmonary Arterial Hypertension: What Is the Impact of Systemic Sclerosis?肺动脉高压患者的肺移植或心肺联合移植：系统性硬化症会产生何种影响？
Exp Clin Transplant. 2017 Dec;15(6):676-684. doi: 10.6002/ect.2016.0209. Epub 2017 May 22.
5
Plasma endothelin-1 levels in patients with systemic sclerosis: influence of pulmonary or systemic arterial hypertension.系统性硬化症患者的血浆内皮素-1水平：肺或系统性动脉高血压的影响。
Ann Rheum Dis. 1995 Sep;54(9):730-4. doi: 10.1136/ard.54.9.730.
6
Cost-Effectiveness of Combination Therapy for Patients With Systemic Sclerosis-Related Pulmonary Arterial Hypertension.系统性硬皮病相关肺动脉高压患者联合治疗的成本效益。
J Am Heart Assoc. 2021 Apr 6;10(7):e015816. doi: 10.1161/JAHA.119.015816. Epub 2021 Mar 24.
7
Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis.Fra-2 转基因小鼠作为一种与系统性硬皮病相关的肺动脉高压新型模型。
Ann Rheum Dis. 2012 Aug;71(8):1382-7. doi: 10.1136/annrheumdis-2011-200940. Epub 2012 Apr 20.
8
Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis.
Am J Med. 1995 Sep;99(3):255-60. doi: 10.1016/s0002-9343(99)80157-0.
9
Pulmonary veno-occlusive disease: a probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis.肺静脉闭塞病：系统性硬化症中一种可能被低估的肺动脉高压病因。
Clin Rheumatol. 2020 May;39(5):1687-1691. doi: 10.1007/s10067-020-04953-4. Epub 2020 Jan 22.
10
Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.系统性硬化症-红斑狼疮重叠综合征中的肺动脉高压
Ann Cardiol Angeiol (Paris). 2019 Oct;68(4):221-225. doi: 10.1016/j.ancard.2018.10.012. Epub 2019 Jan 23.
引用本文的文献
1
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment.系统性硬化症中的肺动脉高压表型：正确的诊断，正确的治疗。
Int J Mol Sci. 2020 Jun 22;21(12):4430. doi: 10.3390/ijms21124430.
本文引用的文献
1
Changes in hemodynamic classification over time are common in systemic sclerosis-associated pulmonary hypertension: insights from the PHAROS cohort.血流动力学分类随时间的变化在系统性硬化症相关肺动脉高压中很常见：来自PHAROS队列的见解。
Pulm Circ. 2018 Apr-Jun;8(2):2045893218757404. doi: 10.1177/2045893218757404.
2
PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.PVDOMICS：一项通过表型组学改善肺血管疾病理解的多中心研究。
Circ Res. 2017 Oct 27;121(10):1136-1139. doi: 10.1161/CIRCRESAHA.117.311737.
3
Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension.针对肺动脉高压患者进行液体负荷试验的临床意义
Chest. 2017 Jan;151(1):119-126. doi: 10.1016/j.chest.2016.08.1439. Epub 2016 Aug 26.
4
Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.毛细血管前、混合性和毛细血管后肺动脉高压：一种病理生理连续统。
J Am Coll Cardiol. 2016 Jul 26;68(4):368-78. doi: 10.1016/j.jacc.2016.05.047.
5
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015年欧洲心脏病学会（ESC）/欧洲呼吸学会（ERS）肺动脉高压诊断和治疗指南：欧洲心脏病学会（ESC）和欧洲呼吸学会（ERS）肺动脉高压诊断和治疗联合工作组：得到以下组织认可：欧洲儿科和先天性心脏病协会（AEPC）、国际心肺移植学会（ISHLT）。
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
6
Exercise haemodynamics may unmask the diagnosis of diastolic dysfunction among patients with pulmonary hypertension.运动血流动力学检查可能会在肺动脉高压患者中揭示舒张功能障碍的诊断。
Eur J Heart Fail. 2015 Feb;17(2):151-8. doi: 10.1002/ejhf.198. Epub 2014 Dec 8.
7
Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension.依赖呼气末楔形压会导致肺动脉高压的误诊。
Eur Respir J. 2014 Aug;44(2):425-34. doi: 10.1183/09031936.00209313. Epub 2014 Jun 12.
8
Updated clinical classification of pulmonary hypertension.肺动脉高压的最新临床分类。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41. doi: 10.1016/j.jacc.2013.10.029.
9
Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension.目前用于确定肺毛细血管楔压的方法容易导致肺动脉高压患者分类出现严重错误。
Am Heart J. 2012 Apr;163(4):589-94. doi: 10.1016/j.ahj.2012.01.024.
10
Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure.由于依赖肺毛细血管楔压而非左心室舒张末期压力导致肺动脉高压的误诊。
Chest. 2009 Jul;136(1):37-43. doi: 10.1378/chest.08-2784. Epub 2009 Mar 2.
Zotero 插件